Interestingly, increased formation of mutp53 aggregates has been associated with temozolomide resistance in glioblastoma cell lines [56], suggesting that release of structurally dysfunctional p53 into the TME might spread chemoresistance across the tumor. The gene discussed is TP53; the disease is neoplasm.